维普期刊资源整合服务平台（V6.5）

54篇 您的检索式：作者名="Siena F"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma ( FOLCETUX study) 显示文摘	PINTO C DI FABIO F SIENA S	2007	Ann Oncol2007，18，3：	1
2	Phase Ⅱ study of cetuximab plus FOLFIRI as first-line treatment in patients with unresectable/metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma (FOLCETUX study):preliminary results显示文摘	Pinto C Di Fabio F Siena S	2006	J Clin Oncol2006，24，18：	1
3	Phase Ⅱ study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)显示文摘	Pinto C Fabio F D Siena S	2007	Annals of Oncology2007，18，3：	1
4	Phase Ⅱ study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)显示文摘	Pinto C Di Fabio F Siena S	2007	Ann Oncol2007，18，3：	1
5	Phase Ⅱ study of eetuximab in combination with FOLFIR1 in patients with untreated advanced gastric or gastroe sophageal junction adenocarcinoma 显示文摘	Pinto C Di Fabio F Siena S	2007	Ann Oncol2007，18，3：	1
6	Phase Ⅱ study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma ( FOLCETUX study) 显示文摘	Pinto C Di Fabio F Siena S	2007	Annals of oncology: official journal of the European So- ciety for Medical Oncology/ESMO2007，18，3：	1
7	Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)显示文摘	Pinto C Di Fabio F Siena S	2007	Ann Oncol2007，18，3：	1
8	Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer显示文摘	Siena S Sartore-Bianchi A Di Nicolantonio F	2009	J Natl Cancer lnst2009，101，19：	1
9	Phase Ⅱ study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma显示文摘	Pinto C Di Fabio F Siena S		0，，03：	1
10	Phase 11 study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study) 显示文摘	Pinto C Di Fabio F Siena S	2007	Ann Oncol2007，18，3：	1
11	Phase Ⅱ study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)显示文摘	Pinto C DiFabio F Siena S		0，，3：	1
12	Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study) 显示文摘	Pinto C DiFabio F Siena S	2007	Ann Oncol2007，18，3：	1
13	Phase II study of cetuximab incombination with FOLFIRI in patients with untreated advanced gas-tric or gastroesophageal junction adenocarcinoma (FOLCETUXstudy)显示文摘	Pinto C Di Fabio F Siena S	2007	Ann Oncol2007，18，3：	1
14	Pentacyclic triterpenes from Cecropia telenitida with immunomodulatory activity on dendritic cells 显示文摘	Peldez G L M Siena J A Alzate F	2013	Rev Bras Farm2013，23，5：	1
15	Biomarkerspredicting clinical outcome of epidermal growth factor receptor-tar- geted therapy in metastatic colorectal cancer 显示文摘	Siena S Sartore-Bianehi A Di Nicolantonio F	2009	J Natl Cancer Inst2009，101，19：	1
16	Adjunctive glycine powder air-polishing for the treatment of peri-implant mucositis:an observational clinical trial显示文摘	De Siena F Corbella S Taschieri S	2015	Int J Dent Hyg2015，13，3：	1
17	Phase I1 study of cetuximab in com- bination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma 显示文摘	Pinto C Di Fabio F Siena S	2007	Ann Oncol2007，18，3：	1
18	Nephelinitic to tholeiitic magma generation in a transtensional tectonic setting:an integrated model for the Iblean volcanism, Sicily显示文摘	Beccaluva L Siena F Coltorti M	1998	Journal of Petrology1998，39，9：	1
19	Biomarkers predicting clinical outcome of epidermal growth factor receptor- targeted therapy in metastatic colorectal cancer 显示文摘	Siena S Sartore-Bianchi A Di Nicolantonio F	2009	Journal of the National Cancer Institute2009，101，：	1
20	Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer显示文摘	Siena S Sartore-Bianchi A Di Nicolantonio F	2009	J Natl Cancer Inst2009，101，19：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示